If you need more lookups,
subscriptions start at $34 USD/month.
Pascal Neuville Location
Strasbourg, FR
Pascal Neuville Work
2018 -now Chairman of the Board of Directors @
2013 -now Member of the Investment Committee @
2011 -now Chairman of the Board of Directors @
2008 -2023 Chief Executive Officer @
2015 -2023 Member of the Strategic Committee @ Defymed
2012 -2015 Member of the Strategic Committee - Excellence Initiative @
2008 -2010 Chairman of the Board of Directors @
2002 -2008 Chief Scientific officer @
1999 -2001 Project Leader @
Pascal Neuville Education
University of Geneva
(Retinoids and smooth muscle cells/restenosis/fibrosis)
1995-1998
University of Strasbourg
PhD (Mol & Cell Biology)
1983-1994
Pascal Neuville Skills
Drug Discovery
Lifesciences
Biotechnology
GPCRs
R&D
Immunology
Technology Transfer
Clinical Development
Genetics
Biochemistry
Neuroscience
Oncology
Science
CRO
Drug Development
Strategy
Medical Devices
Organic Chemistry
Drug Delivery
Cell Culture
Clinical Trials
Chemistry
Bioinformatics
Pharmaceutical Industry
Pharmaceutics
Pharmacology
Molecular Biology
Organic Synthesis
Cell
Biopharmaceuticals
Protein Chemistry
Genomics
Microbiology
Commercialization
Medicinal Chemistry
Cell Biology
Regulatory Affairs
In Vivo
Patents
PCR
Life Sciences
Research and Development (R&D)
Social Media
Recruiting
Investments
Research and Development R&d
Microsoft Office
Research
Marketing
Business Strategy
Sales
Research and Development
Pascal Neuville Summary
Pascal Neuville, based in Strasbourg, FR, is currently a Chairman of the Board of Directors at Quest for change. Pascal Neuville brings experience from previous roles at SATT Conectus Alsace, Axilum Robotics, Domain Therapeutics and Defymed. Pascal Neuville holds a 1995 - 1998 University of Geneva. With a robust skill set that includes Drug Discovery, Lifesciences, Biotechnology, GPCRs, R&D and more. Pascal Neuville has 2 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Pascal Neuville?
Find contact details for 700 million professionals.